Archiv der Kategorie ‘Illumina‘

Illumina neutral – New Analyst Rating from Robert W. Baird & Co. Incorporated

Tuesday, den 27. November 2012

Illumina (ILMN) Downgrade from Outperform to Neutral – Analyst rating from Robert W. Baird

Monday, den 26. November 2012

Illumina neutral – New Analyst Rating from Robert W. Baird & Co. Incorporated

Monday, den 26. November 2012

Roche gibt angediente Illumina-Aktien zurueck

Monday, den 23. April 2012

Roche will Angebot fuer Illumina nicht verlaengern

Wednesday, den 18. April 2012

Roche sieht keinen Grund fuer hoehere Illumina-Offerte

Thursday, den 12. April 2012

WSJ – Illumina lehnt auch hoehere Offerte von Roche ab

Tuesday, den 3. April 2012

Roche-Uebernahmeziel Illumina setzt mehr um als erwartet

Monday, den 2. April 2012

Roche erhoeht Illumina-Angebot auf 51 USD je Aktie

Thursday, den 29. March 2012

Roche dehnt Angebotsperiode fuer Illumina erneut aus

Monday, den 26. March 2012

Roche wendet sich bei Illumina-Uebernahme direkt an die Aktionaere

Tuesday, den 20. March 2012

Illumina neutral – New Analyst Rating from UBS AG

Wednesday, den 29. February 2012

Illumina neutral – New Analyst Rating from UBS AG

Tuesday, den 28. February 2012

Roche verlaengert Uebernahmeangebot fuer Illumina

Monday, den 27. February 2012

Illumina sector perform – New Analyst Rating from RBC Capital Markets

Thursday, den 9. February 2012

Illumina wehrt sich weiter gegen Uebernahme von Roche

Wednesday, den 8. February 2012

Illumina neutral – New Analyst Rating from UBS AG

Friday, den 27. January 2012

Roche-Uebernahmeziel Illumina wehrt sich

Friday, den 27. January 2012

Illumina outperform – New Analyst Rating from Robert W. Baird & Co. Incorporated

Thursday, den 26. January 2012

Illumina (ILMN) Upgrade from Neutral to Outperform – Analyst rating from Robert W. Baird

Wednesday, den 25. January 2012

Illumina outperform – New Analyst Rating from Robert W. Baird & Co. Incorporated

Wednesday, den 25. January 2012

Illumina ( ILMN ) Upgrade from Neutral to Outperform($60) – Analyst rating from Robert W. Baird

Wednesday, den 25. January 2012

Illumina neutral – New Analyst Rating from UBS AG

Monday, den 10. October 2011

Illumina hold – New Analyst Rating from Deutsche Bank Securities

Monday, den 10. October 2011

Illumina ( ILMN ) Downgrade from Buy to Neutral($32) – Analyst rating from UBS

Friday, den 7. October 2011

Illumina (ILMN) Downgrade from Buy to Hold – Analyst rating from Maxim Group

Friday, den 7. October 2011

Illumina ( ILMN ) Downgrade from Buy to Hold – Analyst rating from Maxim Group

Friday, den 7. October 2011

ILMN – Illumina Announces New $100 Million Share Repurchase Authorization

Wednesday, den 3. August 2011

Illumina Shares Plunged

Wednesday, den 27. July 2011

The San Diego company raised its profit and revenue outlook on Tuesday after reporting its second-quarter results. Illumina now says its adjusted profit will grow 33 to 36 percent from 2010 and revenue 24 to 26 percent. In February, it said its profit would grow at least 30 percent while revenue would rise about 20 […]

Illumina 2nd-quarter earnings beat views.

Wednesday, den 27. July 2011

Genetic analysis instrument maker Illumina Inc. said Tuesday that its second-quarter net income edged higher as revenue grew by a third. It raised its annual profit and revenue forecast but the new outlook still came below what analysts were expecting. Net income in the three months through July 3 rose to $30.6 million, or 22 […]

ILMN – Illumina to Present at Leerink Swann Life Science Tools and Diagnostics Roundtable

Wednesday, den 27. July 2011

ILMN – Illumina Reports Financial Results for Second Quarter 2011

Tuesday, den 26. July 2011

ILMN – Illumina Announces First Customer Shipments of the Omni5 BeadChip

Monday, den 25. July 2011

ILMN – Illumina Selected as a Preferred Service Provider for Cancer Research UK

Thursday, den 14. July 2011

ILMN – Illumina Introduces TruSeq(TM) Custom Enrichment Kits for Next Generation Sequencing

Wednesday, den 13. July 2011

ILMN – Illumina to Announce Second Quarter 2011 Financial Results on Tuesday, July 26, 2011

Tuesday, den 12. July 2011

ILMN – Sequenom Announces Multi-Year Supply Agreement With Illumina

Monday, den 11. July 2011

ILMN – University of Washington Department of Genome Sciences Joins Illumina Genome Network

Wednesday, den 29. June 2011

Illumina ( ILMN ) Initial Recommendation Buy – Analyst rating from Maxim Group

Tuesday, den 21. June 2011

Illumina (ILMN) Initial Recommendation – Buy – Analyst rating from Maxim Group

Tuesday, den 21. June 2011

ILMN – Insider Trading Alerts for CVS, Tiffany, Illumina, Dolby, Texas Industries, & Helix

Tuesday, den 21. June 2011

ILMN – Illumina to Webcast Live Presentations at Upcoming Investment Conferences in June

Wednesday, den 1. June 2011

Illumina overweight – New Analyst Rating from Morgan Stanley

Monday, den 16. May 2011

ILMN – GenoLogics Launches LIMS Pre-Configured for Illumina Next-Gen Sequencing Systems and Sample Prep Kits

Tuesday, den 10. May 2011

ILMN – Illumina Reduces Price of Whole Human Genome Sequencing Through Illumina Genome Network

Monday, den 9. May 2011